JP2014514340A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014514340A5 JP2014514340A5 JP2014508740A JP2014508740A JP2014514340A5 JP 2014514340 A5 JP2014514340 A5 JP 2014514340A5 JP 2014508740 A JP2014508740 A JP 2014508740A JP 2014508740 A JP2014508740 A JP 2014508740A JP 2014514340 A5 JP2014514340 A5 JP 2014514340A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- composition according
- policosanol
- acid
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 14
- 229960001109 policosanol Drugs 0.000 claims 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims 9
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims 6
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims 5
- 241000209094 Oryza Species 0.000 claims 5
- 235000007164 Oryza sativa Nutrition 0.000 claims 5
- 239000002253 acid Substances 0.000 claims 5
- 235000009566 rice Nutrition 0.000 claims 5
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims 4
- 230000002378 acidificating effect Effects 0.000 claims 4
- 235000017471 coenzyme Q10 Nutrition 0.000 claims 4
- 229940110767 coenzyme Q10 Drugs 0.000 claims 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims 4
- 235000021283 resveratrol Nutrition 0.000 claims 4
- 229940016667 resveratrol Drugs 0.000 claims 4
- REZQBEBOWJAQKS-UHFFFAOYSA-N triacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO REZQBEBOWJAQKS-UHFFFAOYSA-N 0.000 claims 4
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 3
- 229940012843 omega-3 fatty acid Drugs 0.000 claims 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 3
- 229930003231 vitamin Natural products 0.000 claims 3
- 239000011782 vitamin Substances 0.000 claims 3
- 235000013343 vitamin Nutrition 0.000 claims 3
- 229940088594 vitamin Drugs 0.000 claims 3
- 101000765308 Aspergillus niger N-(5'-phosphoribosyl)anthranilate isomerase Proteins 0.000 claims 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- 229940009098 aspartate Drugs 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- IRHTZOCLLONTOC-UHFFFAOYSA-N hexacosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCO IRHTZOCLLONTOC-UHFFFAOYSA-N 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims 2
- 229940095064 tartrate Drugs 0.000 claims 2
- TYWMIZZBOVGFOV-UHFFFAOYSA-N tetracosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCO TYWMIZZBOVGFOV-UHFFFAOYSA-N 0.000 claims 2
- -1 vial Substances 0.000 claims 2
- 235000019158 vitamin B6 Nutrition 0.000 claims 2
- 239000011726 vitamin B6 Substances 0.000 claims 2
- 229940011671 vitamin b6 Drugs 0.000 claims 2
- NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 claims 1
- RZALONVQKUWRRY-FYZOBXCZSA-N 2,3-dihydroxybutanedioic acid;(3r)-3-hydroxy-4-(trimethylazaniumyl)butanoate Chemical compound OC(=O)C(O)C(O)C(O)=O.C[N+](C)(C)C[C@H](O)CC([O-])=O RZALONVQKUWRRY-FYZOBXCZSA-N 0.000 claims 1
- XOAAWQZATWQOTB-UHFFFAOYSA-M 2-aminoethanesulfonate Chemical compound NCCS([O-])(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-M 0.000 claims 1
- QWJSAWXRUVVRLH-LREBCSMRSA-M 2-hydroxyethyl(trimethyl)azanium;(2r,3r)-2,3,4-trihydroxy-4-oxobutanoate Chemical compound C[N+](C)(C)CCO.OC(=O)[C@H](O)[C@@H](O)C([O-])=O QWJSAWXRUVVRLH-LREBCSMRSA-M 0.000 claims 1
- HJPIFBJPTYTSEX-UHFFFAOYSA-N 2h-tetracen-1-one Chemical compound C1=CC=C2C=C(C=C3C(=O)CC=CC3=C3)C3=CC2=C1 HJPIFBJPTYTSEX-UHFFFAOYSA-N 0.000 claims 1
- 241000228245 Aspergillus niger Species 0.000 claims 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- 208000032928 Dyslipidaemia Diseases 0.000 claims 1
- 235000008100 Ginkgo biloba Nutrition 0.000 claims 1
- 244000194101 Ginkgo biloba Species 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 claims 1
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 claims 1
- 244000113306 Monascus purpureus Species 0.000 claims 1
- 235000002322 Monascus purpureus Nutrition 0.000 claims 1
- 240000000111 Saccharum officinarum Species 0.000 claims 1
- 235000007201 Saccharum officinarum Nutrition 0.000 claims 1
- 208000001435 Thromboembolism Diseases 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 230000003143 atherosclerotic effect Effects 0.000 claims 1
- 150000001805 chlorine compounds Chemical group 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims 1
- 239000005515 coenzyme Substances 0.000 claims 1
- 235000015872 dietary supplement Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- 229960005336 magnesium citrate Drugs 0.000 claims 1
- 235000002538 magnesium citrate Nutrition 0.000 claims 1
- 239000004337 magnesium citrate Substances 0.000 claims 1
- 229940095060 magnesium tartrate Drugs 0.000 claims 1
- MUZDLCBWNVUYIR-ZVGUSBNCSA-L magnesium;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Mg+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O MUZDLCBWNVUYIR-ZVGUSBNCSA-L 0.000 claims 1
- QUIOHQITLKCGNW-TYYBGVCCSA-L magnesium;(e)-but-2-enedioate Chemical compound [Mg+2].[O-]C(=O)\C=C\C([O-])=O QUIOHQITLKCGNW-TYYBGVCCSA-L 0.000 claims 1
- YZURQOBSFRVSEB-UHFFFAOYSA-L magnesium;2-aminoethanesulfonate Chemical compound [Mg+2].NCCS([O-])(=O)=O.NCCS([O-])(=O)=O YZURQOBSFRVSEB-UHFFFAOYSA-L 0.000 claims 1
- 229940057059 monascus purpureus Drugs 0.000 claims 1
- 229930014626 natural product Natural products 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- PXQPEWDEAKTCGB-UHFFFAOYSA-N orotic acid Chemical compound OC(=O)C1=CC(=O)NC(=O)N1 PXQPEWDEAKTCGB-UHFFFAOYSA-N 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000006187 pill Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 229940057070 sugarcane extract Drugs 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 229940066528 trichloroacetate Drugs 0.000 claims 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims 1
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 claims 1
- 239000003981 vehicle Substances 0.000 claims 1
- ABDKAPXRBAPSQN-UHFFFAOYSA-N veratrole Chemical compound COC1=CC=CC=C1OC ABDKAPXRBAPSQN-UHFFFAOYSA-N 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 239000011691 vitamin B1 Substances 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 239000011715 vitamin B12 Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11164526.3 | 2011-05-03 | ||
| EP11164526 | 2011-05-03 | ||
| PCT/EP2012/057428 WO2012150146A1 (en) | 2011-05-03 | 2012-04-24 | Composition useful for the treatment of lipid metabolism disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014514340A JP2014514340A (ja) | 2014-06-19 |
| JP2014514340A5 true JP2014514340A5 (enExample) | 2015-06-11 |
Family
ID=44645300
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014508740A Pending JP2014514340A (ja) | 2011-05-03 | 2012-04-24 | 脂質代謝障害の治療に有用な組成物 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9125903B2 (enExample) |
| EP (1) | EP2704734B1 (enExample) |
| JP (1) | JP2014514340A (enExample) |
| KR (1) | KR101840082B1 (enExample) |
| CN (1) | CN103517711B (enExample) |
| AR (1) | AR086231A1 (enExample) |
| AU (1) | AU2012251818B2 (enExample) |
| CA (1) | CA2834173A1 (enExample) |
| CL (1) | CL2013003144A1 (enExample) |
| CY (1) | CY1116612T1 (enExample) |
| DK (1) | DK2704734T3 (enExample) |
| EA (1) | EA025256B1 (enExample) |
| ES (1) | ES2542412T3 (enExample) |
| HR (1) | HRP20150767T1 (enExample) |
| IL (1) | IL229205A (enExample) |
| ME (1) | ME02180B (enExample) |
| MX (1) | MX361038B (enExample) |
| MY (1) | MY176018A (enExample) |
| NZ (1) | NZ617641A (enExample) |
| PH (1) | PH12013502229A1 (enExample) |
| PL (1) | PL2704734T3 (enExample) |
| PT (1) | PT2704734E (enExample) |
| RS (1) | RS54100B1 (enExample) |
| SG (1) | SG194679A1 (enExample) |
| SI (1) | SI2704734T1 (enExample) |
| SM (1) | SMT201500173B (enExample) |
| UA (1) | UA112182C2 (enExample) |
| WO (1) | WO2012150146A1 (enExample) |
| ZA (1) | ZA201309205B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103202471B (zh) * | 2013-04-25 | 2014-06-11 | 福建永生活力生物工程有限公司 | 一种辅助降血脂的保健食品及其制备方法 |
| WO2016193096A1 (en) | 2015-05-29 | 2016-12-08 | Givaudan Sa | Spray drying |
| CN105395925A (zh) * | 2015-11-27 | 2016-03-16 | 杭州海王生物工程有限公司 | 一种以降血脂为基础的具有降血压和减肥功效的组合物 |
| CN105475580A (zh) * | 2016-01-19 | 2016-04-13 | 苟春虎 | 黑青稞降血脂茶（奶茶） |
| CN105853347A (zh) * | 2016-04-01 | 2016-08-17 | 海南合瑞制药股份有限公司 | 一种左卡尼汀的组合物及其制备方法 |
| IT201600075378A1 (it) * | 2016-07-19 | 2018-01-19 | Farm Legnani Del Dottor De Zanetti Andrea | Integratore alimentare a base di riso rosso fermentato |
| IT201600078969A1 (it) * | 2016-07-27 | 2018-01-27 | Buonamici Gugliemo | Integratore alimentare |
| WO2019018937A1 (en) | 2017-07-26 | 2019-01-31 | Yacyshyn Vincent | REMOVAL OF CONTAMINANT POLYPHENOLS FROM START LOAD POLYPHENOLS |
| EP3735296A4 (en) | 2018-01-04 | 2021-09-08 | Pure Care Pro Llc | NATURAL COMBINED PRODUCTS AND TOTAL BLOOD CHOLESTEROL REGULATION METHODS |
| US11173187B2 (en) | 2018-11-13 | 2021-11-16 | Immortazyme Company Ltd. | Concentrated oil-based polyphenol composition and a method of producing the oil-based polyphenol composition |
| IT201900007002A1 (it) * | 2019-05-20 | 2020-11-20 | Angelo Montecuollo | Integratore alimentare a base di caffè |
| CN112056563A (zh) * | 2020-09-15 | 2020-12-11 | 王胜林 | 用于修复脂质代谢障碍的营养素组合物及其应用 |
| KR102418383B1 (ko) * | 2020-11-19 | 2022-07-07 | 한국식품산업클러스터진흥원 | 천연 복합물을 포함하는 비만 예방 또는 치료용 조성물 |
| IT202200003191A1 (it) * | 2022-02-21 | 2023-08-21 | Inpha Res S R L | Composizione per il controllo delle iperlipidemie |
| CN119424573B (zh) * | 2024-02-05 | 2025-09-26 | 天津铭瑞医药科技有限公司 | 用于治疗高脂血症的中西药物组合 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2903558C2 (de) * | 1978-02-03 | 1994-09-01 | Sigma Tau Ind Farmaceuti | Verwendung von L-Carnitin |
| IT1277953B1 (it) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
| JP3926888B2 (ja) * | 1997-05-27 | 2007-06-06 | 株式会社カネカ | コレステロール低下剤 |
| ITRM20030178A1 (it) | 2003-04-17 | 2004-10-18 | Sigma Tau Ind Farmaceuti | Uso della l-carnitina per il trattamento di patologie cardiovascolari. |
| KR101573316B1 (ko) * | 2004-03-29 | 2015-12-01 | 와이어쓰 엘엘씨 | 종합비타민 및 무기물 영양 보충제 |
| US20100119600A1 (en) * | 2007-06-01 | 2010-05-13 | Joar Opheim | Substances for reducing occurrence of major cardiac events comprising red yeast rice extract and omega-3 polyunsaturated fatty acid or derivative thereof |
-
2012
- 2012-04-24 WO PCT/EP2012/057428 patent/WO2012150146A1/en not_active Ceased
- 2012-04-24 ME MEP-2015-107A patent/ME02180B/me unknown
- 2012-04-24 HR HRP20150767TT patent/HRP20150767T1/hr unknown
- 2012-04-24 PT PT127160380T patent/PT2704734E/pt unknown
- 2012-04-24 EA EA201391622A patent/EA025256B1/ru not_active IP Right Cessation
- 2012-04-24 PL PL12716038T patent/PL2704734T3/pl unknown
- 2012-04-24 DK DK12716038.0T patent/DK2704734T3/en active
- 2012-04-24 ES ES12716038.0T patent/ES2542412T3/es active Active
- 2012-04-24 RS RS20150464A patent/RS54100B1/sr unknown
- 2012-04-24 PH PH1/2013/502229A patent/PH12013502229A1/en unknown
- 2012-04-24 CA CA2834173A patent/CA2834173A1/en not_active Abandoned
- 2012-04-24 UA UAA201314009A patent/UA112182C2/uk unknown
- 2012-04-24 JP JP2014508740A patent/JP2014514340A/ja active Pending
- 2012-04-24 US US14/114,830 patent/US9125903B2/en active Active
- 2012-04-24 AU AU2012251818A patent/AU2012251818B2/en not_active Ceased
- 2012-04-24 CN CN201280021733.2A patent/CN103517711B/zh not_active Expired - Fee Related
- 2012-04-24 KR KR1020137028752A patent/KR101840082B1/ko not_active Expired - Fee Related
- 2012-04-24 SI SI201230258T patent/SI2704734T1/sl unknown
- 2012-04-24 NZ NZ617641A patent/NZ617641A/en not_active IP Right Cessation
- 2012-04-24 SG SG2013080130A patent/SG194679A1/en unknown
- 2012-04-24 MX MX2013012781A patent/MX361038B/es active IP Right Grant
- 2012-04-24 MY MYPI2013003970A patent/MY176018A/en unknown
- 2012-04-24 EP EP12716038.0A patent/EP2704734B1/en active Active
- 2012-05-02 AR ARP120101533A patent/AR086231A1/es unknown
-
2013
- 2013-10-30 CL CL2013003144A patent/CL2013003144A1/es unknown
- 2013-10-31 IL IL229205A patent/IL229205A/en active IP Right Grant
- 2013-11-29 ZA ZA2013/09205A patent/ZA201309205B/en unknown
-
2015
- 2015-07-17 CY CY20151100624T patent/CY1116612T1/el unknown
- 2015-07-20 SM SM201500173T patent/SMT201500173B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014514340A5 (enExample) | ||
| HRP20150767T1 (hr) | Pripravak koristan za lijeäśenje poremeä†aja metabolizma lipida | |
| AU2023200826B2 (en) | Administration of berberine metabolites | |
| US8372451B2 (en) | Compositions and methods for treating depression | |
| AU2020221569B2 (en) | Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use | |
| JP2011500556A (ja) | フコキサンチン又はこれを含有する海藻類抽出物を含有する脂質代謝性疾患の予防又は治療用組成物 | |
| CN115279209A (zh) | 辅酶q产生促进剂和辅酶q产生促进方法 | |
| US20250041322A1 (en) | Heat stress relieving agent | |
| JP2024138435A (ja) | 飲食品組成物 | |
| WO2008059965A1 (en) | Agent for alleviating or preventing stress symptoms and agent for improving mental conditions | |
| JP6773361B2 (ja) | 気分状態改善剤 | |
| WO2005074960A1 (ja) | 機能性飲料及び組成物 | |
| DK2397136T3 (en) | Anti-inflammatory composition | |
| JP2006298792A (ja) | 脂肪蓄積抑制剤及び飲食品 | |
| JP5543655B1 (ja) | ウコン中の有用成分を安定的に含有する飲料 | |
| JP2014208600A (ja) | ウコン中の有用成分を含有する組成物 | |
| RS61160B1 (sr) | Dijetetska kompozicija sa antilipidemijskom aktivnošću | |
| JP2008143811A (ja) | 脂質代謝促進組成物 | |
| JP2012131760A (ja) | 脂肪酸吸収抑制剤 | |
| CN110292592A (zh) | 植物酚及其在治疗或预防嗜酸性食管炎中的用途 | |
| JP4818637B2 (ja) | 低密度リポタンパク質（ｌｄｌ）酸化抑制剤 | |
| JP2009155278A (ja) | 高ホモシステイン血症改善剤 | |
| KR100750661B1 (ko) | 염증성, 알러지성 및 아토피성 질환의 예방 및 치료용 감마리놀렌산 복합체의 제조방법 | |
| JP2004292355A (ja) | 抗ストレス剤 | |
| JP2009023948A (ja) | ドーパミン抑制剤 |